TrianglePUBLICATIONS · 21115860
Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2011 Jan 10
- First author
- Valero V
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Valero V
- type
- Author
- name
- Forbes J
- type
- Author
- name
- Pegram MD
- type
- Author
- name
- Pienkowski T
- type
- Author
- name
- Eiermann W
- type
- Author
- name
- von Minckwitz G
- type
- Author
- name
- Roche H
- type
- Author
- name
- Martin M
- type
- Author
- name
- Crown J
- type
- Author
- name
- Mackey JR
- type
- Author
- name
- Fumoleau P
- type
- Author
- name
- Rolski J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Valero V
- type
- Author
- name
- Forbes J
- type
- Author
- name
- Pegram MD
- type
- Author
- name
- Pienkowski T
- type
- Author
- name
- Eiermann W
- type
- Author
- name
- von Minckwitz G
- type
- Author
- name
- Roche H
- type
- Author
- name
- Martin M
- type
- Author
- name
- Crown J
- type
- Author
- name
- Mackey JR
- type
- Author
- name
- Fumoleau P
- type
- Author
- name
- Rolski J
- type
- Author
- bibliography ids
- nci-bib-a78f88b6ded99765a0456c88
- book metadata
- content sha256
- 156f83f2cf14ce6d2bba78bd33947d267481d578866ab169d351bee2c3c9b018
- document type
- citation
- dois
- 10.1200/JCO.2010.28.6450
- electronic publication date
- display
- 2010 Nov 29
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21115860
- immutable id
- pubmed:21115860@156f83f2cf14ce6d2bba78bd33947d267481d578866ab169d351bee2c3c9b018
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 2
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 149-56
- volume
- 29
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21115860
- provenance
- batch id
- edef4b7f1a2a505cd5a9
- provider
- NCBI PubMed ESummary
- record sha256
- 8a0c7282c69d31487b62c3a51742c38e79c9ab4eb1e0fbac4f817a0202a2d8cc
- response sha256
- d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
- retrieved at
- 2026-09-09T23:46:38.027615+00:00
- publication date
- display
- 2011 Jan 10
- precision
- day
- year
- 2011
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens.
Preserved source evidence · Not medical advice